Keyword News: [stem cell]

Yahoo! Alerts

Yahoo! News - My Alerts - Edit Alert

Tuesday, April 1, 2008 11:31 PM PDT

Stem Cell Sciences Reinstates to Official Quotation (STC.AX, 00828532, 20080402) Huntleys' Stock of the Week via Yahoo!7 Finance Tue, 01 Apr 2008 5:55 PM PDT The suspension of trading in the securities of Stem Cell Sciences will be lifted immediately, following receipt of the company's Full Year Accounts for the period ended 31 December 2007. Christopher and Dana Reeve Foundation Chairman, Peter D. Kiernan, to Provide Keynote Address at 2008 World Stem Cell ... wallstreet:online AG Tue, 01 Apr 2008 12:48 PM PDT The World Stem Cell Summit, www.worldstemcellsummit.com, announced that Peter D. Kiernan, III, Chair Say no to embryonic stem cell research Jambar Tue, 01 Apr 2008 11:36 AM PDT People in favor of stem cell research argue that embryonic stem cells are necessary to the cause because they have the ability to become any type of human cell. They insist that adult stem cells are less important because they do not have the capacity to generate any type of human tissue the way an embryonic cell can. Scripps, Torrey leaders avoid stem-cell subject The Palm Beach Post Tue, 01 Apr 2008 12:13 PM PDT Stem-cell research is a hard topic to dance around when you're part of a panel discussion on biotechnology. NIH to Host Research Symposium on Clinical Applications of Stem Cell Therapies National Institutes of Health Tue, 01 Apr 2008 12:58 PM PDT "Challenges and Promise of Cell-Based Therapies" is a one-day symposium to explore promising research in regenerative medicine using stem cells. The opening plenary session will feature an overview of hematopoietic stem cell therapy. Amorcyte Completes Phase I Trial of Stem Cell Therapy for Acute Myocardial Infarction Business Wire via Yahoo! Finance Tue, 01 Apr 2008 9:56 AM PDT HACKENSACK, N.J.----Amorcyte, Inc. announced today the completion of the phase I clinical trial of its lead product, AMR-001 - an autologous stem cell product for the treatment of damaged heart muscle following acute myocardial infarction . Christopher and Dana Reeve Foundation Chairman, Peter D. Kiernan, to Provide Keynote Address at 2008 World Stem Cell ... Business Wire via Yahoo! Finance Tue, 01 Apr 2008 12:42 PM PDT WASHINGTON----The World Stem Cell Summit, www.worldstemcellsummit.com, announced that Peter D. Kiernan, III, Chair of the Christopher and Dana Reeve Foundation is scheduled to provide a keynote address entitled "Why the Christopher and Dana Reeve Foundation is Investing in Stem Cell Research." Stem Cell Therapy International Appoints Dr. David L. Stark as President in Anticipation of the Upcoming Merger With ... Marketwire via Yahoo! Finance Tue, 01 Apr 2008 6:54 AM PDT Stem Cell Therapy International, Inc. and Histostem Corp.. Mini Stem-Cell Labs Technology Review Tue, 01 Apr 2008 9:21 PM PDT Researchers have grown stem cells in tiny, protective sacs. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating ... PR Newswire via Yahoo! Finance Tue, 01 Apr 2008 11:49 AM PDT Bioheart, Inc. announced today that final six-month, follow-up patient data was presented today during the late-breaking clinical trial sessions at the American College of Cardiology, suggesting that MyoCell® myoblast clinical cell therapy is a safe and potentially effective alternative treatment to standard medical therapy alone for improving heart function among patients with previously ...

See more news stories that match my keyword

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.